TrialInvestigational new drugs2014

Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses.

Wolfgang Uhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.